UCB’s bimekizumab outperforms AbbVie’s Humira in psoriasis patients
The BE SURE study is one of six ongoing clinical trials of bimekizumab in psoriasis and is UCB’s third study that has shown positive results this year.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry
-
SynapCon
SynapCon specialises in the development of innovative software solutions for...
About
SynapCon specialises in the development of innovative software solutions for clinical trial and medical research project management.
FollowMake an Enquiry
-
SWIL Systems
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video...
About
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video conference solutions for clinical researchers, including contract research organisations (CROs), sponsors and institutions.
FollowMake an Enquiry